Log on / register
Feedback | Support | My details

Pre-publication history

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer

Grace M Callagy email, Mark J Webber email, Paul DP Pharoah email and Carlos Caldas email

BMC Cancer 2008, 8:153doi:10.1186/1471-2407-8-153

Pre-publication versions of this article and reviewers' reports

Original submission - Version 2ManuscriptAuthors' comments14 Nov 2007
Reviewer's ReportZhiming Shao05 Dec 2007
Reviewer's ReportMarianne Paesmans21 Dec 2007
Resubmission - Version 3ManuscriptAuthors' comments23 Jan 2008
Reviewer's ReportMarianne Paesmans02 Mar 2008
Resubmission - Version 4ManuscriptAuthors' comments16 Apr 2008
Resubmission - Version 5ManuscriptAuthors' comments22 May 2008
Accepted29 May 2008
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.